📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial. (2023)

First Author: Dargaville PA

Attributed to: Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jama.2023.15694

PubMed Identifier: 37695601

Publication URI: http://europepmc.org/abstract/MED/37695601

Type: Journal Article/Review

Volume: 330

Parent Publication: JAMA

Issue: 11

ISSN: 0098-7484